Company News: Page (1) of 1 - 06/17/14 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Celldex Therapeutics, Inc. - Product Pipeline Review - 2014

  (June 17, 2014)




LONDON, June 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Celldex Therapeutics, Inc. - Product Pipeline Review - 2014

http://www.reportbuyer.com/pharma_healthcare/treatments/celldex_therapeutics_inc_product_pipeline_review_2013.html

Celldex Therapeutics, Inc. - Product Pipeline Review - 2014


Summary

Global Markets Direct's, 'Celldex Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Celldex Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Celldex Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- The report provides brief overview of Celldex Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Celldex Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Celldex Therapeutics, Inc.'s pipeline products


Reasons to buy

- Evaluate Celldex Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Celldex Therapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Celldex Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Celldex Therapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Celldex Therapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Celldex Therapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents

Celldex Therapeutics, Inc. Snapshot 5
Celldex Therapeutics, Inc. Overview 5
Key Information 5
Key Facts 5
Celldex Therapeutics, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Celldex Therapeutics, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Celldex Therapeutics, Inc. - Pipeline Products Glance 13
Celldex Therapeutics, Inc. - Late Stage Pipeline Products 13
Phase III Products/Combination Treatment Modalities 13
Celldex Therapeutics, Inc. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Celldex Therapeutics, Inc. - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Celldex Therapeutics, Inc. - Drug Profiles 17
glembatumumab vedotin 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
rindopepimut 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
CDX-1401 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
CDX-301 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
CDX-2401 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
varlilumab 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CDX-014 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
CDX-1189 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Celldex Therapeutics, Inc. - Pipeline Analysis 28
Celldex Therapeutics, Inc. - Pipeline Products by Target 28
Celldex Therapeutics, Inc. - Pipeline Products by Route of Administration 30
Celldex Therapeutics, Inc. - Pipeline Products by Molecule Type 31
Celldex Therapeutics, Inc. - Pipeline Products by Mechanism of Action 32
Celldex Therapeutics, Inc. - Recent Pipeline Updates 34
Celldex Therapeutics, Inc. - Dormant Projects 42
Celldex Therapeutics, Inc. - Discontinued Pipeline Products 43
Discontinued Pipeline Product Profiles 43
CDX-1135 43
Celldex Therapeutics, Inc. - Company Statement 44
Celldex Therapeutics, Inc. - Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Celldex Therapeutics, Inc. - Key Manufacturing Facilities 51
Appendix 52
Methodology 52
Coverage 52
Secondary Research 52
Primary Research 52
Expert Panel Validation 52
Contact Us 53
Disclaimer 53

List of Tables

Celldex Therapeutics, Inc., Key Information 5
Celldex Therapeutics, Inc., Key Facts 5
Celldex Therapeutics, Inc. - Pipeline by Indication, 2014 7
Celldex Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9
Celldex Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10
Celldex Therapeutics, Inc. - Out-Licensed Products in Pipeline, 2014 11
Celldex Therapeutics, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 12
Celldex Therapeutics, Inc. - Phase III, 2014 13
Celldex Therapeutics, Inc. - Phase II, 2014 14
Celldex Therapeutics, Inc. - Phase I, 2014 15
Celldex Therapeutics, Inc. - Preclinical, 2014 16
Celldex Therapeutics, Inc. - Pipeline by Target, 2014 28
Celldex Therapeutics, Inc. - Pipeline by Route of Administration, 2014 30
Celldex Therapeutics, Inc. - Pipeline by Molecule Type, 2014 31
Celldex Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 33
Celldex Therapeutics, Inc. - Recent Pipeline Updates, 2014 34
Celldex Therapeutics, Inc. - Dormant Developmental Projects,2014 42
Celldex Therapeutics, Inc. - Discontinued Pipeline Products, 2014 43
Celldex Therapeutics, Inc., Other Locations 50
Celldex Therapeutics, Inc., Subsidiaries 50
Celldex Therapeutics, Inc., Key Manufacturing Facilities 51


List of Figures

Celldex Therapeutics, Inc. - Pipeline by Top 10 Indication, 2014 7
Celldex Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9
Celldex Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10
Celldex Therapeutics, Inc. - Pipeline by Top 10 Target, 2014 28
Celldex Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2014 30
Celldex Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2014 31
Celldex Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 32


Read the full report:
Celldex Therapeutics, Inc. - Product Pipeline Review - 2014

http://www.reportbuyer.com/pharma_healthcare/treatments/celldex_therapeutics_inc_product_pipeline_review_2013.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Pro AV, Post/Production, Presentors, Business, Standards/Initiatives, Business Issues, Presentation, Mergers & Acquistion, Inc., Medicine, Disease, Surgery, Medication, Science, Medical, Business, Other,

HOT THREADS on DMN Forums
Content-type: text/html  Rss  Add to Google Reader or
Homepage    Add to My AOL  Add to Excite MIX  Subscribe in
NewsGator Online 
Real-Time - what users are saying - Right Now!

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved